Skip to content
May 14, 2018/

Exiger FCPA Expert to Speak at 12th International Pharmaceutical and Medical Device Compliance Congress

Managing Director ‘George “Ren” McEachern will share his anti-bribery and corruption expertise with senior compliance and legal officers from across the globe at the 12th International Pharmaceutical and Medical Device Congress in Vienna. Ren will join the Anti-Corruption Roundtable on Tuesday, May 15 at 11:30am, alongside representatives from Clifford Chance, Baker & McKenzie, Covington, McGuire Woods and Ernst & Young.The 2018 Congress is centered around relevant Global Pharma and Medical Device Compliance Codes Update, current compliance issues, and emerging trends pertaining to:Anti-corruption and Anti-bribery PolicyRelationships with Patient Support ProgramsDirect Sponsorship of Healthcare Professionals at Third Party EventsThird-Party Risk Management, Due Diligence, and Compliance MonitoringEU General Data Protection Regulation (GDPR)Social Responsibility and the Ethics of Artificial IntelligenceCompliance Issues in Market access and Outcomes-Based Value-Added Services, andThe next generation of ethics and compliance programs.For more information about the event, click here._____________________________________Learn more about Exiger’s Anti-Bribery and Corruption solutions.

trust
VIEW BIO

The risk landscape is constantly changing. Hear about the latest with Exiger.

Media

Exiger WINs Jump Award at FCA TechSprint: Discussion & Demo

The ExCo Vs The Status Quo

Compliance as a Change Agent Through Industry and Beyond

Article

IMC Crossing Borders: How Diligent is Your Due Diligence Provider?